BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Clinical Trials

Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development

Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...

June 03, 2024 | News

AstraZeneca’s TAGRISSO® Shows Significant Improvement in Progression-Free Survival in Phase III LAURA Trial for EGFR-Mutated NSCLC

Positive results from the LAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant a...

June 03, 2024 | News

EMA CHMP Recommends Approval of Sugemalimab for First-Line Treatment of NSCLC

EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and ...

June 03, 2024 | News

Fortrea Launches Comprehensive Solution to Enhance Diversity and Inclusion in Clinical Trials

Fortrea, a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity an...

May 31, 2024 | News

Kexing Biopharm’s Subsidiary Receives Approval for Clinical Trials of Innovative GB08 Growth Hormone

Kexing Biopharm announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clini...

May 31, 2024 | News

HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology

Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...

May 29, 2024 | News

Innovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to SevereInnovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to Severe Plaque Psoriasis

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...

May 28, 2024 | News

Neuren Pharmaceuticals Announces Positive Phase 2 Trial Results for NNZ-2591 in Pitt Hopkins Syndrome

Neuren Pharmaceuticals revealed top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS). This trial demo...

May 28, 2024 | News

Henlius Biotech and Organon Receive EMA Validation for Denosumab Biosimilar HLX14

Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing autho...

May 27, 2024 | News

Tyligand Bioscience Doses First Patient in Phase 1/2 Trial for Innovative KRAS G12D Cancer Therapy

Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the fir...

May 27, 2024 | News

Telix Pharmaceuticals Submits NDA for Innovative Prostate Cancer Imaging Kit to FDA

Telix Pharmaceuticals announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA...

May 27, 2024 | News

Laekna Receives FDA Approval for Phase III Trial of Innovative mCRPC Treatment

Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food an...

May 24, 2024 | News

GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis

Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...

May 23, 2024 | News

GC Biopharma and Novel Pharma Receive FDA IND Approval for MPS IIIA Treatment 'GC1130A'

GC Biopharma and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval. With this appr...

May 21, 2024 | News

Stay Connected